Login / Signup

Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network.

Daniela SegalaMarco BarbieriMariachiara Di NuzzoMelissa BenazziAurora BonazzaLetizia RomaniniBrunella QuartaKristian ScolzAnna MarraDiana CampioniRosario Cultrera
Published in: Global & regional health technology assessment (2024)
Dalbavancin has proven to be a valid therapeutic aid in the organization of a territorial infectious disease network given its prolonged action, which allows the dehospitalization with management of even patients with complex infections in outpatient parenteral antimicrobial therapy.
Keyphrases
  • infectious diseases
  • healthcare
  • palliative care
  • staphylococcus aureus
  • quality improvement
  • mesenchymal stem cells
  • bone marrow